Limula

Limula company information, Employees & Contact Information

Updated May 2026

Quick answer

Limula is a Biotechnology Research company and founded in 2020. It has approximately 25 employees on record. Contact data was last refreshed in May 2026. Find Limula's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.

Company Details

Employees
25
Founded
-
Address
Rte De La Corniche 5, C/o Startlab,switzerland
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Epalinges
Looking for a particular Limula employee's phone or email?

Limula Questions

News

Limula’s End-to-End Cell Processing Platform Enters Beta Testing - Genetic Engineering and Biotechnology News

Limula’s End-to-End Cell Processing Platform Enters Beta Testing Genetic Engineering and Biotechnology News

Limula’s LimONE System Targets Consistency in Stem Cell Transplants - BioPharm International

Limula’s LimONE System Targets Consistency in Stem Cell Transplants BioPharm International

Limula launches automated cell therapy tech - BioProcess International

Limula launches automated cell therapy tech BioProcess International

Limula unveils its cell therapy manufacturing LimONE | GGBa - Greater Geneva Bern area

Limula unveils its cell therapy manufacturing LimONE | GGBa Greater Geneva Bern area

15 Jahre Top100: Schweizer Startups im Rampenlicht und auf dem Weg zur Weltspitze - Moneycab

15 Jahre Top100: Schweizer Startups im Rampenlicht und auf dem Weg zur Weltspitze Moneycab

Biotech Limula secures $6.8M for gene therapy - Tech.eu

Biotech Limula secures $6.8M for gene therapy Tech.eu

Limula on the future of cell therapies: Closed, automated, decentralized - BioProcess International

Limula on the future of cell therapies: Closed, automated, decentralized BioProcess International

Limula Raises $6.8M to Democratise Access to Cell and Gene Therapies with Swiss-Made Platform - Startups Magazine

Limula Raises $6.8M to Democratise Access to Cell and Gene Therapies with Swiss-Made Platform Startups Magazine

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant